Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,000
Closed -$55.2K 797
2024
Q4
$55.2K Hold
5,000
﹤0.01% 423
2024
Q3
$81K Hold
5,000
﹤0.01% 381
2024
Q2
$54.3K Hold
5,000
﹤0.01% 438
2024
Q1
$70K Hold
5,000
﹤0.01% 406
2023
Q4
$52.6K Hold
5,000
﹤0.01% 421
2023
Q3
$45.7K Hold
5,000
﹤0.01% 404
2023
Q2
$36.4K Hold
5,000
﹤0.01% 462
2023
Q1
$42.3K Sell
5,000
-5,000
-50% -$45.2K ﹤0.01% 440
2022
Q4
$75.1K Buy
+10,000
New +$77.4K ﹤0.01% 347
2020
Q4
Sell
-1,000
Closed -$4K 1013
2020
Q3
$4K Buy
+1,000
New +$3.65K ﹤0.01% 812

Other funds holding EOLS

Washington Trust's EOLS Position: Q1 2025 in Review

Washington Trust sold out of Evolus (EOLS) in Q1 2025, closing a stake of 5,000 shares — an estimated $55.2K sold.

Washington Trust first reported a position in EOLS in Q3 2020 and held it in 10 quarters. The position peaked at $81K in Q3 2024. 179 funds tracked by Wall St. Rank hold EOLS as of Q1 2025.

  • Washington Trust reported no remaining Evolus position as of Q1 2025 after selling out during the quarter.
  • Washington Trust sold 5,000 Evolus shares in Q1 2025, an estimated $55.2K.
  • Washington Trust first reported a position in Evolus in Q3 2020 and held it in 10 quarters.
  • Washington Trust's Evolus position peaked at $81K in Q3 2024.
  • 179 funds tracked by Wall St. Rank held Evolus as of Q1 2025.

Based on Washington Trust's 13F filing for Q1 2025, filed 25 Apr 2025.